0001144204-19-019917.txt : 20190416
0001144204-19-019917.hdr.sgml : 20190416
20190416170110
ACCESSION NUMBER: 0001144204-19-019917
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190415
FILED AS OF DATE: 20190416
DATE AS OF CHANGE: 20190416
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ciraolo Michael
CENTRAL INDEX KEY: 0001772484
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38045
FILM NUMBER: 19751515
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neurotrope, Inc.
CENTRAL INDEX KEY: 0001513856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463522381
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: (973) 242-0005
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: BlueFlash Communications, Inc.
DATE OF NAME CHANGE: 20110223
4
1
tv519017_4.xml
OWNERSHIP DOCUMENT
X0306
4
2019-04-15
0
0001513856
Neurotrope, Inc.
NTRP
0001772484
Ciraolo Michael
C/O NEUROTROPE, INC.
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK
NY
10036
0
1
0
0
COO and General Counsel
Stock Option (right to buy)
5.67
2019-04-15
4
A
0
100000
0
A
2029-04-15
Common Stock
100000
100000
D
These securities were issued in connection with the Reporting Person's appointment as a Chief Operating Officer and General Counsel to the Issuer.
25% of the options vest on the date of grant, with the remaining 75% vesting in equal monthly installments over a two year period beginning on April 1, 2019.
/s/ Michael Ciraolo
2019-04-16